Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy.

T Kooistra1, J J Emeis

  • 1Gaubius Laboratory TNO-PG 2215, 2301 CE, Leiden, The Netherlands. t.kooistra@pg.tno.nl

Current Opinion in Chemical Biology
|July 27, 1999
PubMed
Summary

Hormone replacement therapy (HRT) shows promise beyond menopause symptom relief, but clinical trials suggest limitations. New estrogen compounds and receptors offer potential for more targeted drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid ratios representing SCD1, FADS1, and FADS2 activities as candidate biomarkers of early growth and adiposity.

EBioMedicine·2021
Same author

Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.

International journal of obesity (2005)·2016
Same author

Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.

International journal of obesity (2005)·2015
Same author

Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.

Arthritis and rheumatism·2011
Same author

Pathogenesis of postoperative adhesion formation.

The British journal of surgery·2011
Same author

Human visceral adipose tissue and the plasminogen activator inhibitor type 1.

International journal of obesity (2005)·2007

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Hormone replacement therapy (HRT) is expanding beyond menopausal symptom management.
  • Investigating HRT for osteoporosis and cardiovascular disease prevention is increasing.

Purpose of the Study:

  • To evaluate the "one drug/many purposes" concept for HRT.
  • To explore new avenues for targeted estrogen-based therapies.

Main Methods:

  • Review of clinical trial data on HRT efficacy for non-menopausal conditions.
  • Analysis of recent advancements in estrogen receptor research.

Main Results:

  • Current clinical trials indicate that a single HRT drug may not be optimal for multiple conditions.
  • Discovery of a second estrogen receptor presents new therapeutic possibilities.

Conclusions:

  • The broad application of current HRT may be overly optimistic.
  • Developing specific estrogen-like compounds targeting distinct estrogen receptors is a promising future direction for personalized medicine.

Related Experiment Videos